Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: Arnie1, 2HaveKnowledge, Homebrew, MEAD II, rmilman, PharrmaBro
Search This Board: 
Last Post: 3/19/2019 1:59:56 PM - Followers: 281 - Board type: Free - Posts Today: 4

Cyrcadia Asia, Hong Konghttps://www.rouse.com/magazine/news/rouse-ventures-team-scores-win-for-breast-cancer-detection-wearable-cyrcadia/



Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

http://www.firstwarningsystems.com/ became Cyrcadia Health http://cyrcadiahealth.com/

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. http://www.lbti.com

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at http://www.cyrcadiahealth.com/

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine




Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website http://detectedmovie.com/
Detected Facebook https://www.facebook.com/detectedmovie
Detected Twitter https://twitter.com/detectedmovie

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics



iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.




Detected Movie Youtube channel

Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra

Detected: Behind the Scenes with Ironbound Films

Wearable & Social Breast Cancer Screening

Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#25922  Sticky Note “New”Investor Information: confirm 07/17/18 08:30:45 AM
#29163   Gracias, Senor Veritas! MEAD II 03/19/19 01:59:56 PM
#29162   Yep lifeline biotechnologies investor update previously released...clinical confirm 03/19/19 01:12:38 PM
#29161   Take a look under news and see a PharrmaBro 03/19/19 12:41:16 PM
#29160   I agree. However, this article gives 9yrswaiting 03/19/19 11:52:33 AM
#29159   SC: You are right!! There is no news Arnie1 03/18/19 07:31:33 PM
#29158   As you wish. This is the latest (and TheDroids19 03/18/19 06:56:18 PM
#29157   This was just the annual update released a SquirrelCage 03/18/19 06:33:54 PM
#29156   Post it anyway. So, its backed up. 9yrswaiting 03/18/19 05:57:52 PM
#29155   Just copied this same article on Fidelity and TheDroids19 03/18/19 05:52:07 PM
#29154   News Article 9yrswaiting 03/18/19 05:49:26 PM
#29153   3 months from feb 19. May 19 9yrswaiting 03/18/19 05:30:37 PM
#29152   Its correct!! I have to be on 9yrswaiting 03/18/19 05:26:51 PM
#29151   What u think - $20.00 a share by techhead 03/18/19 04:21:47 PM
#29150   True. However I believe in the process, a MEAD II 03/18/19 04:14:26 PM
#29148   The article cannot be located. Please post. MEAD II 03/18/19 03:59:06 PM
#29147   Well it seems 9yr waiting needs to re-research MEAD II 03/18/19 03:55:03 PM
#29146   There are no new news in td yaro1 03/18/19 03:50:14 PM
#29145   I just cross-checked. Scottrade is now TD Ameritrade. MEAD II 03/18/19 03:42:22 PM
#29144   If you date is correct..one month from today....FDA E-7-2 03/18/19 03:15:12 PM
#29143   Feb 19, in Scottrade news. Huge article!!!! 9yrswaiting 03/18/19 02:40:20 PM
#29142   LLBO news: 9yrswaiting 03/18/19 02:30:06 PM
#29141   Here here! MEAD II 03/15/19 12:39:02 PM
#29140   Mead & fish8, there is no question that Arnie1 03/15/19 12:37:21 PM
#29139   I believe we have done what we can MEAD II 03/15/19 11:40:38 AM
#29138   True, i have 24 mil now and waiting fish8 03/15/19 11:35:50 AM
#29137   Thanks. Well good news anyway. I always learn MEAD II 03/15/19 09:19:13 AM
#29136   Mead, fish8 has been with LLBO for two Arnie1 03/15/19 09:04:54 AM
#29135   Congratulations and welcome! MEAD II 03/15/19 03:14:15 AM
#29134   LONGS STILL HERE. Chaka 03/15/19 12:44:50 AM
#29133   Yup, 500,000 at .002 and 500,000 at .0019 fish8 03/14/19 07:32:10 PM
#29132   Some vol today. Fish9. Did you get filled? bme 03/14/19 07:13:49 PM
#29131   I guess you just have to be patient! Arnie1 03/13/19 07:38:09 PM
#29130   Yes i dont understand it, guess i will fish8 03/13/19 07:29:48 PM
#29129   This is surprising to me. Because your offer Arnie1 03/13/19 07:21:50 PM
#29128   Dont think its my broker, i have 23mil fish8 03/13/19 07:02:06 PM
#29127   Etrade fish8 03/13/19 06:59:54 PM
#29126   Fish8 if you don't mind, who is your Broker? Arnie1 03/13/19 06:59:05 PM
#29125   Tried again today, no luck so i lowered fish8 03/13/19 06:30:21 PM
#29124   Almost back to .00015. Nice job! 9yrswaiting 03/13/19 06:03:02 PM
#29123   That's the best way with a GTC limit MEAD II 03/12/19 05:17:46 PM
#29122   No one selling many, i had it at .0021 fish8 03/12/19 05:16:49 PM
#29121   No luck today, maybe will take AON off fish8 03/12/19 05:14:40 PM
#29120   Absolutely, with LLBO I always place GTC orders MEAD II 03/12/19 03:24:45 PM
#29119   Fish8. If you have AON, take it off bme 03/12/19 03:09:36 PM
#29118   I hope you were filled. If you are MEAD II 03/12/19 02:22:00 PM
#29117   Fish 8: you should be able to buy Arnie1 03/12/19 11:54:53 AM
#29116   Had a buy order for 1 mil at fish8 03/12/19 11:39:32 AM
#29115   Good post Forever, confirm 03/11/19 12:46:21 PM
#29109   Long here (2008). I've followed the board for Foreverlong 03/10/19 08:50:59 PM
#29107   “Huge Business Potential”...Just love those words...tic toc confirm 03/10/19 07:58:24 AM